Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects
Cancers · 20.03.2023 · 15 (6) · 1864
DOI: 10.3390/cancers15061864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.03.2023. Verfasst von Yuta Shibamoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Narita Memorial Proton Center, 78 Shirakawa-cho, Toyohashi 441-8021, Japan. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
This article reviews the results of various non-surgical curative treatments for operable breast cancer. Radiotherapy is considered the most important among such treatments, but conventional radiotherapy alone and concurrent chemoradiotherapy do not achieve high cure rates. As a radiosensitization strategy, intratumoral injection of hydrogen peroxide before radiation has been investigated, and high local control rates (75–97%) were reported. The authors treated 45 patients with whole-breast radiotherapy, followed by stereotactic or intensity-modulated radiotherapy boost, with or without a radiosensitization strategy employing either hydrogen peroxide injection or hyperthermia plus oral tegafur-gimeracil-oteracil potassium. Stages were 0–I in 23 patients, II in 19, and III in 3. Clinical and cosmetic outcomes were good, with 5-year overall, progression-free, and local recurrence-free survival rates of 97, 86, and 88%, respectively. Trials of carbon ion radiotherapy are ongoing, with promising interim results. Radiofrequency ablation, focused ultrasound, and other image-guided ablation treatments yielded complete ablation rates of 20–100% (mostly ≥70%), but long-term cure rates remain unclear. In these treatments, combination with radiotherapy seems necessary to treat the extensive intraductal components. Non-surgical treatment of breast cancer is evolving steadily, with radiotherapy playing a major role. In the future, proton therapy with the ultra-high-dose-rate FLASH mode is expected to further improve outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Narita Memorial Proton Center, 78 Shirakawa-cho, Toyohashi 441-8021, Japan.
- Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita-shi 565-0871, Japan.
- Department of Radiology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
ORCID-Profile: Yuta Shibamoto
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shibamoto, Y., & Takano, S. (2023). Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects. Cancers, 15(6), 1864. https://doi.org/10.3390/cancers15061864
Vancouver
Shibamoto Y, Takano S. Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects. Cancers. 2023;15(6):1864. doi:10.3390/cancers15061864
BibTeX
@article{Shibamoto2023,
author = {Shibamoto, Yuta and Takano, Seiya},
title = {Non-Surgical Definitive Treatment for Operable Breast Cancer: Current Status and Future Prospects},
journal = {Cancers},
year = {2023},
volume = {15},
number = {6},
pages = {1864},
doi = {10.3390/cancers15061864}
}
EUVIMED